Official 2023 U.S. DOL Form 5500 summary for Weland Clinical Laboratories, P.c. (Weland Entities 401(k) Plan · EIN 42-1174563 · PN 001): $16.98M net assets, 93 active participants, and $29.02 per $10,000 (29.02 bps).
| Plan Sponsor | Weland Clinical Laboratories, P.c. |
|---|---|
| Filing Identifier | Weland Entities 401(k) Plan · EIN 42-1174563 · PN 001 |
| Plan Category & State | 401(k) Defined Contribution (IA) |
| Asset-Size Peer Cohort | $5M-$25M |
| Plan Net Assets (2023) | $16.98M |
| Active Participants | 93 |
| Direct Admin Fee Rate | $29.02 per $10,000 (29.02 bps) |
| Cohort Peer Median | $34.74 per $10,000 (34.74 bps) |
| Primary Recordkeeper / Provider | Voya Financial |
| Schedule H Line 4a Remittance | Timely Employer Remittance (0 reported on Line 4a) |
Browse all 78,373 plans & Schedule C vendors · Methodology · Meru AI